MOUNTAIN VIEW, Calif., Dec. 20, 2012 /PRNewswire/ --
- Milestone helps accelerate adoption of FinFET technology for faster and more power efficient Systems on Chips (SoC)s
- Collaboration delivers foundation for 3D device modeling and physical design rule support
- Test chip qualifies FinFET process and Synopsys ® DesignWare ® Embedded Memories
Synopsys, Inc. (Nasdaq: SNPS), a global leader providing software, IP and services used to accelerate innovation in chips and electronic systems, today announced that its multi-year collaboration with Samsung on FinFET technology has achieved a critical milestone: the successful tapeout of the first test chip on Samsung's 14LPE process. While the FinFET process offers significant power and performance benefits compared to the traditional planar process, the move from two-dimensional transistors to three-dimensional transistors introduces several new IP and EDA tool challenges such as modeling. The multi-year collaboration delivered the foundational modeling technologies for 3D parasitic extraction, circuit simulation and physical design-rule support of FinFET devices. Synopsys' comprehensive solution for embedded memory, physical design, parasitic extraction, timing analysis and signoff is built on this foundation.
"FinFET transistors can deliver lower power consumption and higher device performance, but they also bring tough challenges," said Dr.
Kyu-Myung Choi, vice president of System LSI infrastructure design center, Device Solutions, Samsung Electronics. "We chose Synopsys as our FinFET collaboration partner to solve these challenges, because of our successful history together at 20 nanometer and other nodes. We continue to pool our expertise to deliver innovative FinFET solutions."
Synopsys' FinFET-ready IP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts